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Abstract
Background: Assessing RNA quality is essential for gene expression analysis, as the inclusion of degraded
samples may influence the interpretation of expression levels in relation to biological and/or clinical
parameters. RNA quality can be analyzed by agarose gel electrophoresis, UV spectrophotometer, or
microcapillary electrophoresis traces, and can furthermore be evaluated using different methods. No
generally accepted recommendations exist for which technique or evaluation method is the best choice.
The aim of the present study was to use microcapillary electrophoresis traces from the Bioanalyzer to
compare three methods for evaluating RNA quality in 24 fresh frozen invasive breast cancer tissues: 1)
Manual method = subjective evaluation of the electropherogram, 2) Ratio Method = the ratio between the
28S and 18S peaks, and 3) RNA integrity number (RIN) method = objective evaluation of the
electropherogram. The results were also related to gene expression profiling analyses using 27K
oligonucleotide microarrays, unsupervised hierarchical clustering analysis and ontological mapping.
Results: Comparing the methods pair-wise, Manual vs. Ratio showed concordance (good vs. degraded
RNA) in 20/24, Manual vs. RIN in 23/24, and Ratio vs. RIN in 21/24 samples. All three methods were
concordant in 20/24 samples. The comparison between RNA quality and gene expression analysis showed
that pieces from the same tumor and with good RNA quality clustered together in most cases, whereas
those with poor quality often clustered apart. The number of samples clustering in an unexpected manner
was lower for the Manual (n = 1) and RIN methods (n = 2) as compared to the Ratio method (n = 5).
Assigning the data into two groups, RIN ≥ 6 or RIN < 6, all but one of the top ten differentially expressed
genes showed decreased expression in the latter group; i.e. when the RNA became degraded. Ontological
mapping using GoMiner (p ≤ 0.05; ≥ 3 genes changed) revealed deoxyribonuclease activity, collagen,
regulation of cell adhesion, cytosolic ribosome, and NADH dehydrogenase activity, to be the five
categories most affected by RNA quality.
Conclusion: The results indicate that the Manual and RIN methods are superior to the Ratio method for
evaluating RNA quality in fresh frozen breast cancer tissues. The objective measurement when using the
RIN method is an advantage. Furthermore, the inclusion of samples with degraded RNA may profoundly
affect gene expression levels.
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Background
The development of high-throughput technologies such
as microarrays, allowing for the parallel analysis of the
expression of thousands of genes from a tumor in one sin-
gle experiment, has provided new tumor biological
knowledge. In breast cancer, for example, microarrays
have been suggested to be useful for predicting clinical
outcome and for tailoring treatment strategies for individ-
ual patients [1-3]. This approach may also increase the
ability to identify new targets for more specific therapies.
Studies using this technique have furthermore revealed
differences in gene expression profiles between different
subgroups of breast cancer, e.g. between hereditary and
sporadic breast cancer, and between estrogen receptor
(ER) positive and ER negative tumors [1,4,5].
Microarrays were first described by Schena and co-workers
in 1995 [6]. The different parts of this technique involve
RNA extraction, control of RNA quality, hybridization,
and data analysis. Extraction of RNA is a long process,
often in the presence of contaminants and ribonucleases
that may degrade RNA. RNA is sensitive and can hence
easily be degraded at room temperature. The most com-
mon technique for controlling the quality of RNA is the
characterization with agarose gel electrophoresis and/or
using a UV spectrophotometer. However, these tech-
niques are not sensitive enough and are easily influenced
by contaminants in the sample. Therefore new techniques
have been developed, e.g. the Agilent 2100 Bioanalyzer
[7]. The Bioanalyzer is based on a lab-on-a-chip micro-flu-
ids technology, and the software generates an electrophe-
rogram and a gel-like image. With this new technique data
can be evaluated in different ways, either manually by
inspecting the electropherogram, or by calculating the
28S/18S ratio. Recently a new feature in the Bioanalyzer
software has been implemented, the RNA integrity
number (RIN) [8,9]. Furthermore, Auer and co-workers
have developed a mathematical model for quantitative
characterization of RNA degradation, the Degradometer
[10]. No generally accepted recommendations exist, how-
ever, regarding which technique or evaluation method is
the best choice for downstream applications requiring
high quality RNA. Moreover, to our knowledge, no study
has previously systematically evaluated to what extent the
RNA quality influences the interpretation of gene expres-
sion profiling for routinely collected frozen breast cancer
samples.
In the present study we have focused on 1) different ways
of evaluating the quality of RNA, 2) how the quality of
RNA influences microarray-based gene expression analy-
ses, and 3) which type of gene categories that are affected
by decreased RNA quality.
The results indicate that the Manual and RIN methods are
superior to the Ratio method for evaluating RNA quality
in fresh frozen breast cancer tissues. The objectively
obtained measurement of the RIN method is, in addition,
clearly an advantage. Furthermore, the inclusion of sam-
ples with degraded RNA can profoundly influence gene
expression profiles, and hence clustering of samples as
well as absolute expression levels of individual genes.
Results
RNA quality
We analyzed the RNA quality using three different meth-
ods; Manual, Ratio and RIN, respectively (see Methods).
Visual inspection of the Bioanalyzer electropherograms
showed that of the six samples included, the majority
were degraded at room temperature, but after different
lengths of time [see Additional file 1]. Three examples are
shown in Fig. 1. Based on manual evaluation, the Manual
method, Sample 3 was degraded at 2 minutes, Sample 5 at
30 minutes, whereas Sample 6 was not affected at all
within the 30 minute time-frame (Fig. 1a–c).
Similar results were obtained using the Ratio method.
According to the Ratio method however, Sample 3 was
considered good at 10 minutes (Fig. 1a), whereas Samples
5 and 6 were considered poor at 10 minutes (Fig. 1b) and
2–3 minutes (Fig. 1c), respectively. The RIN method, on
the other hand, yielded results almost identical to the
Manual method. One exception was, however, noted;
Sample 5 (Fig. 1b, 10 min) was considered good with the
Manual method, but not with the RIN method.
The electropherograms from one of the samples (Sample
3), showed an unexpected appearance over time (Fig. 1a).
It was degraded at 2 and 10 minutes, but at 30 minutes,
the RNA was considered partly degraded with the Manual
method and good with the Ratio and RIN methods.
In summary, pair-wise comparisons of the methods
revealed that Manual vs. Ratio showed concordance in 20/
24, Manual vs. RIN in 23/24, and Ratio vs. RIN in 21/24
samples. All three methods showed concordant results in
20 of the 24 samples.
Gene expression
Our hypothesis was that if the RNA quality of the sample
was good for all four time periods, the corresponding gene
expression profiles should be similar and the samples
should consequently cluster together. Conversely, upon
RNA degradation, changes in gene expression profiles
would cause the sample replicates to cluster apart. Using
unsupervised hierarchical clustering to assess which sam-
ples clustered together, we noted that the samples clus-
tered into two separate groups, one including most of the
good samples (including those partly degraded) and oneBMC Molecular Biology 2007, 8:38 http://www.biomedcentral.com/1471-2199/8/38
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including most of the degraded samples, irrespective of
evaluation method (Fig. 2).
When using the Manual method, all samples but one (Fig.
2a, arrow) clustered as we hypothesized. The correspond-
ing number of samples, clustering in an unexpected way
with the other two methods (i.e. samples considered to be
of good RNA quality clustering with degraded samples or
vice versa) was five (Ratio method; Fig. 2b) and two (RIN
method; Fig. 2c), respectively.
Bioanalyzer electropherograms Figure 1
Bioanalyzer electropherograms. Bioanalyzer electropherograms of three samples, a) Sample 3, b) Sample 5, and c) Sample 
6 after different lengths of time: 50 seconds, 2–3 minutes, 10 minutes, and 30 minutes, respectively. Three methods were used 
for evaluating the RNA quality, see Methods. Pearson correlation coefficients were obtained, when the gene expression levels 
of the sample for the different time periods at room temperature were related to the gene expression levels of the sample left 
at room temperature for 50 seconds.
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Unsupervised hierarchical clustering Figure 2
Unsupervised hierarchical clustering. Unsupervised hierarchical clustering was used to assess which samples clustered 
together based on their gene expression profiles. A. Clustering according to the Manual evaluation method; green = good, blue 
= partly degraded, red = degraded. B. Clustering according to the Ratio method; green = ratio ≥ 0.65 (i.e. good), red = ratio < 
0.65 (i.e. degraded), and black = N/A (i.e. not available). C. Clustering according to the RIN method; green = RIN ≥ 6 and red = 
RIN < 6. Arrows indicate samples clustering in an unexpected manner, according to the respective methods.
a)
b)
c)BMC Molecular Biology 2007, 8:38 http://www.biomedcentral.com/1471-2199/8/38
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Concentrating on RIN values we assigned the data into
two groups: RIN ≥ 6 or RIN < 6 and compared the gene
expression profiles of these two groups to see whether
there was a significant difference for any given reporter ×
between the two groups. We performed a gene score anal-
ysis in Bio Array Software Environment (BASE) [11] to
find statistical significance in terms of false discovery rates
(FDR), and a permutation test was performed to obtain an
estimate of the rate of differentially expressed reporters.
Out of 14,288 reporters, 7,672 distinguished the two
groups with an FDR of 5%. With an FDR of 0.01%, 238
reporters were able to distinguish between the two groups.
The top ten most differentially expressed genes are shown
in Fig. 3. All but one showed decreased gene expression
levels in the RIN < 6 compared to the RIN ≥ 6 group. Sim-
ilar results were obtained when a t-test and a Mann-Whit-
ney test were used to calculate probabilities (data not
shown).
Gene Ontology (GO) mapping using GoMiner [12], (p ≤
0.05 and ≥ 3 changed genes in each category) revealed
deoxyribonuclease activity, GO: 0004536 (12%); colla-
gen, GO: 0005581 (9.1%); regulation of cell adhesion,
GO: 0030155 (8.3%); cytosolic ribosome (sensu Eukary-
ota), GO: 0005830 (7.3%); and NADH dehydrogenase
activity GO: 0003954 (6.7%) to be the five most affected
categories, [see Additional file 2].
Discussion
Good RNA quality is essential for obtaining reliable result
from microarray experiments. The inclusion of samples
with degraded RNA may influence the statistical analysis
and hence the interpretation of gene expression levels in
relation to biological and/or clinical data. Results should
reflect true biological differences and not differences due
to poor RNA integrity.
In the present study, three different evaluation methods
were compared, one manual and two objective (the Ratio
and RIN methods). In 20/24 (83%) samples, all three
methods came to the same result (good or degraded
RNA). The Manual and RIN methods were concordant in
23/24 (96%) samples, whereas the Ratio method showed
discordant results with the other two methods in four and
three samples, respectively. In some of the discordant
samples, the discrepancy could be explained by values
near the cut-off. The results indicate that the Manual and
RIN methods are more similar to one another than the
Ratio method is to either. This finding is in line with the
evaluation principles. While both the Manual and RIN
methods take the whole electropherogram into consider-
ation, manually or objectively, the Ratio method relies
only on the ratio between the 28S and 18S peaks. Further-
more, the ratio calculation is based on area measurements
and is heavily dependent on the definitions of the start
and end of the peaks. In addition, small peaks make this
measurement even more uncertain, which is often the
case with partly degraded samples. Therefore, the ribos-
omal ratio may not be sufficient to evaluate RNA degrada-
tion efficiently in all instances. Copois and co-workers,
using colorectal cancer, liver metastases, and normal
colon, compared the ratio method with the computer-
based RIN and Degradometer methods, as well as with an
in-house "RNA Quality Scale" method, and came to the
conclusion that the 28S/18S ratio resulted in misleading
categorization [13]. To address this issue, Sotiriou and co-
workers used an arbitrary cut-off of 15% of the total RNA
area, and 28S/18S > 1.1 in their investigation of the corre-
lation between histological grade and gene expression
profiles in breast cancer [14].
Imbeaud and co-workers obtained similar results in their
study including both cell lines and different normal tis-
sues, demonstrating ambiguity with the Ratio method
[15]. When ribosomal ratios were calculated from identi-
cal samples, a large degree of variability was observed.
Manual evaluation of the RNA quality through visual
inspection, on the other hand, provided consistent data.
In general, there was a good agreement between the man-
Top ten differentially expressed genes Figure 3
Top ten differentially expressed genes. The top ten 
most differentially expressed genes between RIN ≥ 6 and 
RIN < 6. LAMA4 = laminin 4, DCN = decorin, OR10C1 = 
olfactory receptor, LGALS1 = lectin galactoside-binding, 
PNMA1 = paraneoplastic antigen, neuron and testis specific 
protein, TCEA1 = transcription elongation factor A, MRLC2 = 
myosin regulatory light chain, KIFAP3 = kinesin-associated 
protein 3, GNG10 = guanine nucleotide binding protein, and 
C6orf89 = chromosome 6 open reading frame 89. Filled cir-
cles represent outliers.
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ual classification, the degradation factor and the RIN
method, but not with the ratio values [15].
In concordance with the above-mentioned studies, the
results of our investigation demonstrate that the gene
expression profiles change considerably upon RNA degra-
dation. We hypothesized that if the RNA quality in differ-
ent samples from the same breast tumor was good, the
corresponding gene expression profiles should be similar,
and the samples should consequently cluster together. In
contrast, when RNA is degraded, changes in gene expres-
sion profiles would cause the samples to cluster apart. Our
findings indicate that the results of the RNA quality eval-
uation using the Manual and RIN methods were more
concordant with the results of the clustering analyses than
when using the Ratio method. While only one (Manual)
and two (RIN) sample replicates clustered apart, five sam-
ples clustered in an unexpected way when the Ratio
method was used, i.e. samples considered to be of good
RNA quality clustered with degraded samples or vice versa.
These results indicate that the Manual and RIN methods
are more concordant and superior to the Ratio method for
evaluating RNA quality in fresh frozen breast cancer sam-
ples. An advantage with the RIN method in comparison
with the Manual method is that it yields an objective
measurement, whereas the subjective interpretation of the
Manual method, especially for the partly degraded group,
may show both intra- and inter-individual variation. In
order to validate the cut-off of 6 for the RIN method, we
also tested 5 or 7 as cut-offs. The number of samples clus-
tering in an unexpected way was thereby increased to
three and seven, respectively. The use of 6 as a cut-off was
also strengthened when the RIN values were compared to
the Pearson correlation coefficients of the association
between the gene expression of the samples for the differ-
ent time points (2–3 minutes to 50 minutes) and the gene
expression after 50 seconds.
One sample showed an unexpected appearance over time,
as the RNA quality appeared superior after extended expo-
sure to room temperature compared to shorter time peri-
ods when it was deemed degraded (Fig. 1a). This
surprising observation may be explained by tumor heter-
ogeneity.
Of the top ten most differentially expressed genes, all but
one showed decreased gene expression levels in the RIN <
6 compared to the RIN ≥ 6 group (Fig. 3), suggesting deg-
radation of RNA transcripts to occur as RNA quality dete-
riorates. Furthermore, gene ontology mapping using
GoMiner revealed deoxyribonuclease activity, collagen,
regulation of cell adhesion, cytosolic ribosome, and
NADH dehydrogenase activity to be the five categories
most affected by RNA quality. One may speculate that
genes belonging to these categories could potentially be
used as markers for RNA quality in gene profiling studies
using fresh frozen breast cancer tissue. It would be inter-
esting to evaluate if this strategy could be used as a poten-
tial qualification approach for already collected gene
expression data sets, and to investigate whether clustering
analyses are influenced due to the inclusion of degraded
transcripts belonging to these ontological categories.
Our results demonstrate that RNA was degraded at room
temperature, but the RNA in the six samples showed vari-
able sensitivity. This variation may be explained by differ-
ent sensitivity to room temperature due to e.g. differences
in tissue composition. Some samples may be rich in fatty
tissue, whereas others may be rich in epithelial cancer
cells. Furthermore, the amount of connective tissue may
also influence the amount and quality of extracted RNA.
Another explanation for the differences between samples
may be that the time period from surgical excision until
the sample is placed at -80°C varies and that they are col-
lected from several pathological departments, with differ-
ent routines. The tissue composition and suboptimal
sample collection procedures may also explain the rela-
tively low ratio values obtained in breast cancer, in com-
parison with other tissue materials. In a recent publication
from our group [16], we had approximately the same per-
centage of samples with poor RNA quality (9%) in com-
parison with other studies using similar criteria for
evaluation of the RNA quality (10–20%) [17,18].
From the electropherograms it was, furthermore, demon-
strated that RNA degradation is a gradual process. Not all
RNA follows the same pattern during degradation; how-
ever, the larger ribosome is typically degraded first, result-
ing in a decrease and broadening of this peak.
Consequently, as degradation proceeds, there is a decrease
in the 28S to 18S ribosomal ratio and an increase in the
baseline signal between the two ribosomal peaks.
Conclusion
The results indicate that the Manual and RIN methods are
superior to the Ratio method for evaluating RNA quality
in fresh frozen breast cancer tissues. The RIN method gives
an objective measure of RNA quality, while the Manual
method may be subject to inter-, as well as intra-observer
variation. In addition, the inclusion of samples with
degraded RNA may affect the outcome of the study, as the
levels of gene expression are highly dependent upon RNA
integrity. Based on our experience, we recommend RIN
values ≥ 6 to be used for fresh frozen breast cancer tissue.
Methods
Study design
Frozen samples from six patients were retrieved from the
tissue bank (-80°C) owned by the South Swedish Breast
Cancer Group. In order to obtain RNA of different quality,BMC Molecular Biology 2007, 8:38 http://www.biomedcentral.com/1471-2199/8/38
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four equally sized pieces (by weight) from each invasive
breast cancer sample were placed at room temperature for
four different lengths of time: 50 seconds, 2–3 minutes,
10 minutes, and 30 minutes, after which the samples were
placed in liquid nitrogen.
The ethical committee at Lund University approved this
project.
RNA isolation and quality control
The samples were pulverized with a Micro-dismembrator
II (B. Braun Biotech Int., Germany), and RNA was
extracted using Trizol reagent (Invitrogen, Carlsbad, CA),
and purified with Qiagen RNeasy Midi columns (Qiagen,
Chatsworth, CA). The RNA concentration was determined
using a Nanodrop Spectrophotometer (NanoDrop Tech-
nologies, Wilmington, DE). The RNA quality was assessed
using an Agilent 2100 Bioanalyzer (Agilent Technologies,
Santa Clara, CA) together with the reagents in the RNA
6000 Nano LabChip kit. All samples were within the kit
capacity (5–500 ng/μl). The Agilent 2100 Bioanalyzer
generates an electropherogram and a gel-like image and
displays results such as sample RNA concentration and
the so called ribosomal ratio, i.e. the ratio between the
ribosomal subunits, 28S/18S.
The electropherogram can be evaluated in three ways.
With visual inspection, (Manual method) the quality of
RNA is considered good if the electropherogram shows
two distinct peaks, one for 28S and one for 18S, and a flat
baseline (e.g. Fig. 1a, 50 sec.). The electropherogram of a
degraded sample contains many small peaks and a highly
elevated baseline (e.g. Fig. 1b, 30 min.). In addition to the
good and degraded are the partly degraded samples; two
peaks are visible, but the baseline is elevated (e.g. Fig. 1c,
50 sec.). Most of these are considered good enough for
further analysis, i.e. to proceed to the hybridization step.
However, methods that rely on visual inspection are sub-
jective and have a tendency to vary over time. A more
objective way to evaluate the quality of RNA may be to use
a certain threshold for the 28S/18S ratio as a cut-off (Ratio
method). From previous studies, we have established a
threshold for the Bioanalyzer ratio at ≥ 0.65 (data not
shown). A more recent approach is to use the RNA Integ-
rity Number (RIN) method, which is a standardization of
RNA quality control [8,19]. It is a software algorithm that
has been developed to extract information about RNA
sample integrity from Bioanalyzer electrophoretic trace.
The RIN method was developed to eliminate the effect of
individual interpretation on RNA quality control. It takes
the entire electropherogram into consideration and is
based on a numbering system from 1 to 10, where 1 rep-
resents the most degraded RNA and 10 represents intact
RNA. When the RIN tool was developed, input data
included approximately 1,300 total RNA samples from
various tissues, all with varying levels of RNA integrity
[19]. After a threshold value has been established, this
value can be used in the RNA quality control procedure,
but if any experimental parameter is changed (e.g. type of
organism, type of tissue, type of microarray platform,
RNA extraction procedure, etc.) the validation procedure
needs to be repeated. There are, thus, no established cut-
off values and each laboratory needs to establish their
own.
Previously, we have compared RIN values with results
from the Manual method in a series of 163 breast tumors,
used in other projects. In these projects the samples were
extracted in, essentially, the same way as in the present
study. All samples considered to be of good RNA quality
with the Manual method had RIN values between 6 and 8
(median 7). The median values for the partly degraded
and degraded were 6 (range: 3–7) and 4 (range: 2–6),
respectively. Based on these results we considered values
greater or equal to 6 to represent good RNA. This cut-off
was therefore also used in the present study.
cDNA microarrays
Five micrograms of tumor RNA was labeled with Cy3®
dCTP (Amersham Biosciences, Piscataway, NJ), and 5 μg
of reference RNA (Stratagene, La Jolla, CA), consisting of
a pool of ten different tumor cell lines, was labeled with
Cy5®  dCTP (Amersham Biosciences, Piscataway, NJ),
according to the manufacturer's instructions using the rea-
gents in the ChipShot™ labeling system kit (Corning Inc.,
Corning, NY).
Arrays were produced by the Swegene DNA Microarray
Resource Centre, Department of Oncology at Lund Uni-
versity, Sweden, using a set of 26,819 70 base-pair human
oligonucleotide probes (Operon Ver. 2.1. and Ver 2.1.1
upgrade, Cat.No. 810516 and 810518), which were
obtained from Operon Biotechnologies, Inc. (Huntsville,
AL). The probes represent 16,641 gene symbols.
Prior to hybridization, slides were UV-cross linked at 800
mJ/cm2 and pre-treated using the Pronto!™ Plus System 6
(Corning, Inc., Corning, NY), according to the manufac-
turer's instructions. Arrays were scanned at two wave-
lengths using an Agilent G2505A DNA microarray scanner
(Agilent Technologies, Santa Clara, CA), with 10 μm reso-
lution. Gene Pix Pro 4.0 software (Axon Instruments, Inc.,
Union City, CA), was used for image analysis. Gene
names were linked to the spots and spots with poor qual-
ity were manually excluded. Raw-data are available at
Gene Expression Omnibus [20].
Data analysis
Background correction of Cy3 and Cy5 intensities was cal-
culated, using the median feature and the median localBMC Molecular Biology 2007, 8:38 http://www.biomedcentral.com/1471-2199/8/38
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background intensities provided in the data matrix.
Within arrays, intensity ratios for individual features were
calculated as background corrected intensity of tumor
sample divided by background corrected intensity of ref-
erence sample. The data matrix was uploaded to BASE
[11], where the data analysis took place.
Spots with intensities lower than zero, and spots that were
flagged bad or not found were excluded. Reporters that
were not present in 100% of the arrays were filtered out,
and the data was normalized using Lowess [21], resulting
in 14,288 reporters in the final analysis. Unsupervised
hierarchical clustering, using Euclidean distance, was per-
formed in BASE. Concentrating on RIN values, we
assigned the data into two groups: RIN ≥ 6 or RIN < 6, and
compared the gene expression profiles of these two
groups to see whether there was a significant difference for
any given reporter × between the two groups. We per-
formed a gene score analysis in BASE to find statistical sig-
nificance in terms of false discovery rates (FDR), and a
permutation test was performed to obtain an estimate of
the rate of differentially expressed reporters.
Ontological mapping using the publicly available soft-
ware GoMiner [12] was performed to investigate the most
significantly affected GO categories. A p-value ≤ 0.05 was
used, and only categories with ≥ 3 changed genes were
considered in the analysis. A percentage of the number of
genes that were changed in each category was calculated.
Validating the RIN threshold value
In order to validate the RIN cut-off value, the RIN values
were compared to the Pearson correlation coefficients
(Fig. 4). In BASE, Pearson correlation coefficients were
obtained, when the gene expressions of the sample for the
different time points at room temperature were related to
the gene expression of the sample left 50 seconds at room
temperature. Poor correlations should correspond to
lower RIN values, and good correlations should equal
higher RIN values (Fig. 4). If the correlation coefficient of
the gene expression is the true value for the RNA quality,
only two samples did not obtain RIN values as expected,
i.e. a low correlation coefficient and a RIN value above the
cut-off or vice versa (Fig. 4). Both samples had a RIN value
close to the cut-off. This strengthened the choice of 6 as
the cut-off for the RIN method in the present study.
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Correlation between the RIN value and Pearson correlation Figure 4
Correlation between the RIN value and Pearson cor-
relation. In order to evaluate the RIN cut-off value of 6, we 
compared it to Pearson correlation coefficients. Pearson cor-
relation coefficients were obtained, when the gene expres-
sion levels of the samples for the different time periods at 
room temperature, were related to the gene expression lev-
els of the samples left 50 seconds at room temperature. If 
the correlation coefficient of the gene expression level is the 
true value, two samples obtain unexpected RIN values, i.e. a 
low correlation coefficient and a RIN value above the cut-off 
or vice versa (arrows, RIN 5 = Sample 5, 10 min and RIN 6 = 
Sample 3, 30 min).
- 0. 40
- 0. 20
0. 00
0. 20
0. 40
0. 60
0. 80
1. 00
RIN
C
o
r
r
e
l
a
t
i
o
n
 
c
o
e
f
f
i
c
i
e
n
t
17 6 5 4 3 2 0 8Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Molecular Biology 2007, 8:38 http://www.biomedcentral.com/1471-2199/8/38
Page 9 of 9
(page number not for citation purposes)
References
1. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie
T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC,
Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL: Gene
expression patterns of breast carcinomas distinguish tumor
subclasses with clinical implications.  Proc Natl Acad Sci USA
2001, 98:10869-10874.
2. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M,
Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ,
Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene
expression profiling predicts clinical outcome of breast can-
cer.  Nature 2002, 415:530-536.
3. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW,
Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D,
Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H,
Rodenhuis S, Rutgers ET, Friend SH, Bernards R: A gene-expres-
sion signature as a predictor of survival in breast cancer.  N
Engl J Med 2002, 347:1999-2009.
4. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R,
Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, Wilfond B, Borg
A, Trent J, Raffeld M, Yakhini Z, Ben-Dor A, Dougherty E, Kononen
J, Bubendorf L, Fehrle W, Pittaluga S, Gruvberger S, Loman N, Johan-
nsson O, Olsson H, Sauter G: Gene-expression profiles in hered-
itary breast cancer.  N Engl J Med 2001, 344:539-548.
5. Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A, Ferno
M, Peterson C, Meltzer PS: Estrogen receptor status in breast
cancer is associated with remarkably distinct gene expres-
sion patterns.  Cancer Res 2001, 61:5979-5984.
6. Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitor-
ing of gene expression patterns with a complementary DNA
microarray.  Science 1995, 270:467-470.
7. Hawtin P, Hardern I, Wittig R, Mollenhauer J, Poustka A, Salowsky R,
Wulff T, Rizzo C, Wilson B: Utility of lab-on-a-chip technology
for high-throughput nucleic acid and protein analysis.  Electro-
phoresis 2005, 26:3674-3681.
8. Mueller OLS, Schroeder A: RNA integrity number (RIN) stand-
ardization of RNA quality control.  Tech Rep 5989-1165EN, Agi-
lent Technologies, Application note, 2004 [http://www.chem.agilent.com/
scripts/LiteraturePDF.asp?iWHID=37507].
9. Agilent Technologies; RNA Integrity Number (RIN)
[http:www.chem.agilent.com/scripts/generic.asp?LPAGE=14975&ind
col=Y&prodcol=Y]
10. Auer H, Lyianarachchi S, Newsom D, Klisovic MI, Marcucci G, Kor-
nacker K: Chipping away at the chip bias: RNA degradation in
microarray analysis.  Nat Genet 2003, 35:292-293.
11. Saal LH, Troein C, Vallon-Christersson J, Gruvberger S, Borg A,
Peterson C: Bio Array Software Environment (BASE): a plat-
form for comprehensive management and analysis of micro-
array data.  Genome Biol 2002, 3:SOFTWARE0003..
12. Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, Sunshine M, Nar-
asimhan S, Kane DW, Reinhold WC, Lababidi S, Bussey KJ, Riss J, Bar-
rett JC, Weinstein JN: GoMiner: a resource for biological
interpretation of genomic and proteomic data.  Genome Biol
2003, 4:R28.
13. Copois V, Bibeau F, Bascoul-Mollevi C, Salvetat N, Chalbos P, Bareil
C, Candeil L, Fraslon C, Conseiller E, Granci V, Maziere P, Kramar A,
Ychou M, Pau B, Martineau P, Molina F, Del Rio M: Impact of RNA
degradation on gene expression profiles: Assessment of dif-
ferent methods to reliably determine RNA quality.  J Biotech-
nol 2007, 127:549-559.
14. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H,
Farmer P, Praz V, Haibe-Kains B, Desmedt C, Larsimont D, Cardoso
F, Peterse H, Nuyten D, Buyse M, Van de Vijver MJ, Bergh J, Piccart
M, Delorenzi M: Gene expression profiling in breast cancer:
understanding the molecular basis of histologic grade to
improve prognosis.  J Natl Cancer Inst 2006, 98:262-272.
15. Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E,
Mueller O, Schroeder A, Auffray C: Towards standardization of
RNA quality assessment using user-independent classifiers
of microcapillary electrophoresis traces.  Nucleic Acids Res 2005,
33:e56.
16. Nimeus-Malmstrom E, Ritz C, Eden P, Johnsson A, Ohlsson M, Strand
C, Ostberg G, Ferno M, Peterson C: Gene expression profilers
and conventional clinical markers to predict distant recur-
rences for premenopausal breast cancer patients after adju-
vant chemotherapy.  Eur J Cancer 2006, 42:2729-2737.
17. Pawitan Y, Bjohle J, Amler L, Borg AL, Egyhazi S, Hall P, Han X, Hol-
mberg L, Huang F, Klaar S, Liu ET, Miller L, Nordgren H, Ploner A,
Sandelin K, Shaw PM, Smeds J, Skoog L, Wedren S, Bergh J: Gene
expression profiling spares early breast cancer patients from
adjuvant therapy: derived and validated in two population-
based cohorts.  Breast Cancer Res 2005, 7:R953-964.
18. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov
D, Timmermans M, Meijer-van Gelder ME, Yu J, Jatkoe T, Berns EM,
Atkins D, Foekens JA: Gene-expression profiles to predict dis-
tant metastasis of lymph-node- negative primary breast can-
cer.  Lancet 2005, 365:671-679.
19. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann
M, Lightfoot S, Menzel W, Granzow M, Ragg T: The RIN: an RNA
integrity number for assigning integrity values to RNA meas-
urements.  BMC Mol Biol 2006, 7:3.
20. Gene Expression Omnibus,   [http://www.ncbi.nlm.nih.gov/
projects/geo/]
21. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP: Nor-
malization for cDNA microarray data: a robust composite
method addressing single and multiple slide systematic vari-
ation.  Nucleic Acids Res 2002, 30(4):el5.